Saturday, October 11, 2014

CIDRAP's recommendations regarding Ebola's AIRBORNE properties

From Meryl Nass MD's Anthrax Vaccine blog:

We strongly urge the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to seek funds for the purchase and transport of PAPRs to all healthcare workers currently fighting the battle against Ebola throughout Africa—and beyond.


These statements are based on two lines of reasoning. The first is that no one located at a distance from an infected individual has contracted the disease, or the converse, every person infected has had (or must have had) "direct" contact with the body fluids of an infected person.

This reflects an incorrect and outmoded understanding of infectious aerosols, which has been institutionalized in policies, language, culture, and approaches to infection control. We will address this below. Briefly, however, the important points are that virus-laden bodily fluids may be aerosolized and inhaled while a person is in proximity to an infectious person and that a wide range of particle sizes can be inhaled and deposited throughout the respiratory tract.

US Ebola: Frieden Said Every Hospital Was Ready. He is Wrong.

CDC: Interim Guidance for Specimen Collection, Transport, Testing, and Submission for Persons Under Investigation for Ebola Virus Disease in the United States

Was the "Ebola virus" made in a Lab?

Ebola Virus – Produced in Lab ?

(PDF) The Bioterrorist Threat of Ebola in East Africa

No comments:

Post a Comment